NCT05109936View on ClinicalTrials.gov

Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration

PHASE3RecruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

August 2, 2023

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2027

Conditions
Gout
Interventions
DRUG

Adenuric

Immediate prescription (at randomization) of ADENURIC 80 mg / day (febuxostat), hypo-uricemic treatment, for a period of 2 x 6 weeks

Trial Locations (6)

Unknown

RECRUITING

CHU de Caen, Caen

RECRUITING

Centre Hospitalier Public du Cotentin, Cherbourg

RECRUITING

CHG Dieppe, Dieppe

RECRUITING

CHI Elbeuf, Louvier, Val de Reuil, Elbeuf

RECRUITING

GH Le Havre, Le Havre

RECRUITING

CHU de Rouen, Rouen

All Listed Sponsors
lead

University Hospital, Rouen

OTHER